Doha Itani
Overview
Explore the profile of Doha Itani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stewart K, Itani D, Mulherin A, Hayes R
SAGE Open Med Case Rep
. 2023 Nov;
11:2050313X231213928.
PMID: 38022863
Proliferating pilar tumors are rare, benign, exophytic neoplasms, which can closely resemble a squamous cell carcinoma. We describe a patient with a large benign exophytic tumor on the scalp that...
2.
Arora R, Haynes L, Kumar M, McNeil R, Ashkani J, Nakoneshny S, et al.
Cancer Gene Ther
. 2023 Jan;
30(5):752-765.
PMID: 36635327
There are few prognostic biomarkers and targeted therapeutics currently in use for the clinical management of oral squamous cell carcinoma (OSCC) and patient outcomes remain poor in this disease. A...
3.
Cheung C, Smith A, Albadine R, Bigras G, Bojarski A, Couture C, et al.
Lung Cancer
. 2021 Sep;
160:127-135.
PMID: 34509095
Patients with non-small cell lung cancer (NSCLC) harboring ROS proto-oncogene 1 (ROS1) gene rearrangements show dramatic response to the tyrosine kinase inhibitor (TKI) crizotinib. Current best practice guidelines recommend that...
4.
Hildebrand K, Singla A, McNeil R, Marritt K, Hildebrand K, Zemp F, et al.
PLoS One
. 2021 Jul;
16(7):e0253864.
PMID: 34242269
Sarcomas are rare, difficult to treat, mesenchymal lineage tumours that affect children and adults. Immunologically-based therapies have improved outcomes for numerous adult cancers, however, these therapeutic strategies have been minimally...
5.
Kendal J, Singla A, Affan A, Hildebrand K, Al-Ani A, Ungrin M, et al.
Clin Orthop Relat Res
. 2020 Dec;
478(12):2921-2933.
PMID: 33275394
Background: The putative benefit of rhBMP-2 is in the setting of limb reconstruction using structural allografts, whether it be allograft-prosthetic composites, osteoarticular allografts, or intercalary segmental grafts. There are also...
6.
Singh N, Al-Ruwaisan M, Batra A, Itani D, Ghatage P
J Obstet Gynaecol Can
. 2020 Sep;
42(12):1483-1488.
PMID: 32900677
Objective: Premenopausal women with uterine leiomyosarcoma experience different issues than menopausal women with this malignancy. This study evaluated the clinical profile and factors affecting survival outcomes in premenopausal women with...
7.
Craig S, Khalil M, Eszlinger M, Itani D, Koebel M, Koro K, et al.
Surgery
. 2020 May;
169(1):22-26.
PMID: 32471652
Background: Classification of thyroid follicular neoplasms can be challenging for pathologists. Introduction of noninvasive follicular thyroid neoplasms with papillary-like nuclear features, the utilization of immunohistochemistry, and molecular analysis are all...
8.
Torlakovic E, Albadine R, Bigras G, Boag A, Bojarski A, Cabanero M, et al.
J Thorac Oncol
. 2020 Apr;
15(8):1328-1337.
PMID: 32304736
Introduction: The programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) assay is used to select patients for first or second-line pembrolizumab monotherapy in NSCLC. The PD-L1 IHC 22C3 pharmDx assay requires an...
9.
Chen C, Lohavanichbutr P, Zhang Y, Houck J, Upton M, Abedi-Ardekani B, et al.
Oral Oncol
. 2019 Dec;
100:104487.
PMID: 31835136
Objectives: To test the performance of an oral cancer prognostic 13-gene signature for the prediction of survival of patients diagnosed with HPV-negative and p16-negative oral cavity cancer. Materials And Methods:...
10.
Le N, Singla A, Geng Y, Han J, Seehafer K, Prakash G, et al.
Chem Commun (Camb)
. 2019 Sep;
55(76):11458-11461.
PMID: 31535684
We report a polymer-based sensor that rapidly detects cancer based on changes in serum protein levels. Using three ratiometric fluorescence outputs, this simple system identifies early stage and metastatic lung...